Stocktoria
LENSAR, Inc. LNSR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-09-21
LENSAR, Inc. statistics & valuation
Market cap$68.1M
P / S1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -42.1% | -19.9% | -29.0% | -57.1% | -57.0% |
| Net margin | -58.7% | -58.7% | -34.1% | -56.3% | -56.9% |
| FCF margin | -25.5% | -4.5% | -23.5% | -42.3% | -27.1% |
| Return on assets | -48.0% | -47.4% | -20.7% | -35.7% | -29.5% |
| Return on equity | 131.7% | -645.9% | -43.0% | -47.4% | -35.7% |
| Current ratio | 1.15 | 2.80 | 3.99 | 2.95 | 5.14 |
| Revenue growth | 9.2% | 26.9% | 19.2% | 2.6% | 30.6% |
Source: SEC EDGAR filings · CIK 0001320350 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.